Clinical trials
Polyneuropathies trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2019 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Erasmus Medical Center | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polyneuropathies | 5 |
| Amyloidosis | 3 |
| Alzheimer Disease | 1 |
| Amyloid Neuropathies, Familial | 1 |
| Autoimmune Diseases | 1 |
| Cardiomyopathies | 1 |
| Critical Illness | 1 |
| Guillain-Barre Syndrome | 1 |
| Heart Diseases | 1 |
| Immune System Diseases | 1 |
Trials
Showing 26 to 5 of 5. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.